CIK 0001016504 · Non-accelerated filer<br>Smaller reporting company
INTEGRATED BIOPHARMA INC
Sign in to watch- Ticker
- INBP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 222407475
- Phone
- 9739260816
- Business address
- 225 LONG AVENUE, BUILDING 15, HILLSIDE, NJ, 07205
- Former names
- INTEGRATED HEALTH TECHNOLOGIES INC, CHEM INTERNATIONAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 26 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-24 | Canarick Robert Director | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2019-05-24 | Masi Dina Chief Financial Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2019-05-24 | DESANTIS CARL Director | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2019-05-24 | KAY CHRISTINA Co-Chief Executive Officer | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2019-05-24 | RIVA SHEPPARD Co-Chief Executive Officer | Grant or award · Stock Options (right to buy) | +250,000 | 250,000 | ||
| 2019-05-24 | KAY E GERALD Executive Chairman & President | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2018-12-19 | KAY CHRISTINA Executive Vice President | Grant or award | +50,000 | $0.14 | $7K | 1,423,467 |
| 2018-12-19 | KAY CHRISTINA Executive Vice President | Grant or award | +50,000 | $0.14 | $7K | 1,173,467 |
| 2018-12-19 | RIVA SHEPPARD Executive Vice President | Grant or award | +50,000 | $0.14 | $7K | 1,423,467 |
| 2018-12-19 | RIVA SHEPPARD Executive Vice President | Grant or award | +50,000 | $0.14 | $7K | 1,173,467 |
| 2018-12-19 | KAY E GERALD Chief Executive Officer | Grant or award | +100,000 | $0.10 | $10K | 5,262,556 |
| 2018-07-31 | Milmoe William H. Director | Other acquisition | +8,230,769 | $0.65 | $5.3M | 188,667 |
| 2018-07-31 | DESANTIS CARL Director | Other acquisition | +8,230,769 | $0.65 | $5.3M | 117,409 |
| 2018-07-31 | CD Financial, LLC 10% owner | Other acquisition | +8,230,769 | $0.65 | $5.3M | 10,524,173 |
| 2018-07-24 | Milmoe William H. Director | Conversion · 6% secured convertible note due 2020, as amended | +0 | $5,350,000.00 | $0 | 0 |
| 2018-07-24 | DESANTIS CARL Director | Conversion · 6% secured convertible note due 2020, as amended | −0 | $5,350,000.00 | $0 | 0 |
| 2018-07-24 | CD Financial, LLC 10% owner | Conversion · 6% secured convertible note due 2020, as amended | −0 | $5,350,000.00 | $0 | 0 |
| 2016-11-18 | LAPLACA JOSEPH Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2016-11-18 | Milmoe William H. Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2016-11-18 | Canarick Robert Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 |
Page 6 of 8 · 160 trades